microdose semaglutide dose Microdosing chart: The complete guide What is Microdosing a GLP-1?
Description
This dual effect on weight and glycaemic control is vital for reducing long-term diabetes complications
Major trials including STEP 1-4 (semaglutide) and SURMOUNT 1-4 (tirzepatide) demonstrate 15-22% average weight loss over 68 weeks with improved cardiovascular markers and glucose control
Total cholesterol is a composite number thats less useful in isolation than the individual components
Additionally, as your body weight drops, the same GLP-1 dose may no longer suppress appetite as effectively, requiring ongoing dose optimization
Spacing new injections at least one inch apart from previous injection sites gives tissue time to heal between doses
[DOI] [PubMed] [Google Scholar] 282.Frias J.P., et al
